Concepedia

Publication | Closed Access

The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.

DOI

90

Citations

0

References

1998

Year

Tore Julsrud Berg, Jes Thorn Clausen, Peter A. Torjesen, Knut Dahl‐Jørgensen, H.‐J. Bangstad, K. F. Hanssen
Diabetes Care

Abstract

Serum levels of CML are increased in patients with type 1 diabetes. This increase precedes the development of micro- and macrovascular complications.